1. Actinium Pharmaceuticals, Inc. (ATNM)
Historical Data
Find the latest Actinium Pharmaceuticals, Inc. (ATNM) stock quote, history, news and other vital information to help you with your stock trading and investing.
2. ATNM Interactive Stock Chart | Actinium Pharmaceuticals, Inc. Stock
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
3. ATNM Jul 2024 7.500 call (ATNM240719C00007500)
Find the latest ATNM Jul 2024 7.500 call (ATNM240719C00007500) stock quote, history, news and other vital information to help you with your stock trading ...
Find the latest ATNM Jul 2024 7.500 call (ATNM240719C00007500) stock quote, history, news and other vital information to help you with your stock trading and investing.
4. ATNM May 2024 12.500 call (ATNM240517C00012500)
Find the latest ATNM May 2024 12.500 call (ATNM240517C00012500) stock quote, history, news and other vital information to help you with your stock trading ...
Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.
5. Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical ...
Jun 17, 2020 · Is (ATNM) Outperforming Other Medical Stocks This Year ... Yahoo Finance• 16h ago. Stocks are about to hit a 'wall of money ...
Is (ATNM) Outperforming Other Medical Stocks This Year?
6. NYSEMKT: ATNM Actinium Pharmaceuticals Inc Stock
ATNM's financial health ; Profit margin · Revenue. $0.0. Net Income. -$8.7M ; Assets to liabilities · Assets. $88.4M · Liabilities. $44.5M ; Cash flow · Operating. -$ ...
Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or adoptive cell therapies. Its lead product candidate is Iomab-B, which is in a pivotal Phase III clinical trial as an induction and conditioning agent in patients over the age of 55 with relapsed or refractory acute myeloid leukemia prior to receiving a bone marrow transplant, also known as a hematopoietic stem cell transplant. The company is also developing Actimab-A, its lead alpha-particle drug candidate that is in a Phase II trial for patients newly diagnosed with AML age 60 and over; and Actimab-M, a drug candidate, for the treatment of patients with penta refractory multiple myeloma in a Phase 1 clinical trial. Its Antibody Warhead Enabling technology platform is currently being utilized in a research collaboration with Astellas Pharma, Inc. The company was founded in 2000 and is based in New York, New York.
7. Actinium Pharmaceuticals, Inc. stock splits - Digrin
Market Capitalization: 263.9 million. Links: ATNM on Yahoo Finance · Disclaimer | Privacy policy | FAQ | Digrin.com news | Affiliates (20% commission lifetime).
Price: $7.16
8. ATNM: Actinium Pharmaceuticals Inc - Stock Price, Quote and News - CNBC
Get Actinium Pharmaceuticals Inc (ATNM:NYSE American) real-time stock quotes, news, price and financial information from CNBC.
9. Actinium Pharmaceuticals (ATNM) - Market capitalization
Market capitalization of Actinium Pharmaceuticals (ATNM). Market cap: $0.22 ... by Yahoo Finance info icon. $0.21 Billion. by CompaniesMarketCap ...
As of June 2024 Actinium Pharmaceuticals has a market cap of $0.20 Billion. This makes Actinium Pharmaceuticals the world's 6938th most valuable company according to our data.
